Complement Levels in Mice with Tumors
Author Information
Author(s): F. Hartveit
Primary Institution: Gade Institute, Department of Pathology, University of Bergen, Norway
Hypothesis
The growth of a genetically incompatible tumor transplant is accompanied by a reduction in the serum complement level.
Conclusion
Mice with tumors showed significantly lower complement levels compared to non-tumor bearing mice.
Supporting Evidence
- The complement levels in non-tumor bearing mice were similar, with a mean titre of 1:64.
- Tumor-bearing mice showed lower complement titres, averaging at 1:4.
- The drop in complement levels was consistent across different tumor types.
Takeaway
When mice have tumors, their blood has less of a special protein that helps fight infections compared to mice without tumors.
Methodology
Serum and ascitic fluid were collected from tumor-bearing and non-tumor-bearing mice, and complement factor C1 was titrated.
Limitations
The study did not explore the exact mechanisms behind the drop in complement levels.
Participant Demographics
Mice from a closed colony and F1 hybrids, approximately 6 months old.
Want to read the original?
Access the complete publication on the publisher's website